Miryam Mebarki

1.1k citations
19 papers · 628 indexed · h-index 11
Topics
CAR-T cell therapy research (9 papers)Mesenchymal stem cell research (8 papers)Tissue Engineering and Regenerative Medicine (4 papers)
Partner nations
FranceUnited StatesItaly

In The Last Decade

Miryam Mebarki

19 papers receiving 622 citations

Peers

Miryam Mebarki
Comparison fields: 5 of 85
  • Genetics 193
  • Molecular Biology 189
  • Oncology 146
  • Surgery 136
  • Biomedical Engineering 118
Replace Anna Valeria Samarelli with:
Anna Valeria Samarelli Italy
Paula Kolar Germany
Ludovic Melly Switzerland
Anwar J. Siddiqui Sweden
Jens Tuischer Germany
A. van Dijk Netherlands
Paweł Łęgosz Poland
Alfred Gugerell Austria
Miryam Mebarki relative to Anna Valeria Samarelli Italy Anna Valeria Samarelli's profile →
Citations per field
00.5×11.7×
Anna Valeria Samarelli · 1×
Citations per year

Countries citing papers authored by Miryam Mebarki

Since Specialization
Citations

This map shows the geographic impact of Miryam Mebarki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miryam Mebarki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miryam Mebarki more than expected).

Fields of papers citing papers by Miryam Mebarki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miryam Mebarki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miryam Mebarki. The network helps show where Miryam Mebarki may publish in the future.

Co-authorship network of co-authors of Miryam Mebarki

This figure shows the co-authorship network connecting the top 25 collaborators of Miryam Mebarki. A scholar is included among the top collaborators of Miryam Mebarki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miryam Mebarki. Miryam Mebarki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 36
5 4
6 43
7 20
8 19
9 116
10 3
11 3
12 26
13 8
14 6
15 22
16 22
17 67
18 67
19 162

About Miryam Mebarki

Miryam Mebarki is a scholar working on Genetics, Occupational Therapy and Oncology, having authored 19 papers that have together received 628 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Mesenchymal stem cell research (8 papers) and Tissue Engineering and Regenerative Medicine (4 papers). The work is most often cited by research in Genetics (193 citations), Critical Care and Intensive Care Medicine (59 citations) and Urology (39 citations). Miryam Mebarki has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Jérôme Larghero, Audrey Cras, Pierre Layrolle, Nathalie Chevallier, Béatrice Matot, Pierre G. Carlier, Tarek Sharshar, Corinne Huchet, Clément Crochemore and David Briand. Their work appears in journals such as Nature Communications, Blood and Acta Biomaterialia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026